CONNECT WITH US
HealthTech

HealthTech

From supply chains to cancer research: How causal AI is opening new research paths

Medical Xpress logo

Published on

Add as a preferred source on Google
From supply chains to cancer research: How causal AI is opening new research paths

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

How can automotive supply-chain research inform a new line of inquiry in cancer treatment research? For Constructor University Lecturer and Postdoctoral Researcher Ishansh Gupta, the answer is causal AI—a form of artificial intelligence that goes beyond simple pattern recognition to analyze why certain patterns exist, and help predict outcomes of changes.

Gupta's research into AI applications in the automotive sector has produced multiple publications—including his latest study on supplier risk and evaluation published in the journal Supply Chain Analytics. Now, Gupta is exploring how this same technology could potentially support health professionals with decision-making during cancer treatment, research that has been accepted for presentation next month at NeurIPS.

The connection between the two projects was sparked in 2025 when Gupta attended the Lindau Nobel Laureate Meeting, where he met Nobel Prize–winning researchers who challenged him to think beyond the traditional bounds of his field. When asked which field outside of economics had most influenced his life, the answer was clear and immediate: medicine, the profession of both his parents. Gupta found himself challenged to consider whether he could apply his work in industrial AI and the automotive sector to other fields like human health.

" said Gupta.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.